MAIA
MAIA Biotechnology, Inc.Healthcare·Biotechnology
$1.39
$85M market cap
Revenue
$0.0M
Free Cash Flow
$-12.3M
Rev Growth
+0.0%
FCF Margin
0.0%
P/FCF
--
EV/FCF
--
Fwd EV/EBITDA
--
Fair Value
--
Upside
--
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded in 2018 and is headquartered in Chicago, Illinois.
2-Year Price History
$1.28-73.1%
Quarterly Financials & Projections
Quarterly Waterfall ($ M)
| Period | Rev | EBITDA | OpIn | NI | OCF | FCF | CapEx | Cash | Debt | Shares | ROIC | IntCov | EV/EBITDA | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Act | 2026-Q1 | 0.0 | -7.0 | -7.0 | -6.4 | -5.3 | -5.3 | -0.0 | 34.4 | 0.0 | 32.1 | -- | -- | -- |
| Act | 2025-Q4 | 0.0 | -3.6 | -4.3 | -3.6 | -7.0 | -7.0 | -0.0 | 8,658 | 0.0 | 32.1 | -2.2% | -- | -- |
Valuation & Metrics
Market Stats
Price$1.39
Market Cap$85M
Enterprise Value$50M
P/S Ratio0.0x
P/FCF--
EV/FCF--
FCF Margin (TTM)0.0%
FCF Yield-14.6%
Dividend Yield (TTM)--
Annual Dilution0.0%
CurrencyUSD
TTM Financial Snapshot
Revenue$0.0M
Net Income$-10.0M
Free Cash Flow$-12.3M
Revenue Growth (YoY)+0.0%
EBITDA Margin0.0%
Net Margin0.0%
FCF Margin0.0%
CapEx % of Revenue0.0%
SBC % of Revenue0.0%
ROIC-2.2%
WC Change % Rev0.0%
Interest Coverage--
Forward Outlook & Risk
Short Interest
Short % of Float--
Short Shares3.2M
Days to Cover5.0
Change (vs Prior)+11.7%
Need at least 2 settlement dates for chart
Employees
Headcount13
Revenue / Employee$0
Gross Profit / Employee$0
Cash Runway
33.5months
WATCH
Institutional Ownership
Headline & net flow
NEUTRAL
Net flow · —still filing
No float data — flow unavailable.
Ownership composition
Active
29.4%(+28.2% YoY)
24 filers
hedge / family / endowment
Retail funds
—
Fidelity, Schwab, 401(k)
Passive
8.6%(+5.3% YoY)
7 filers
Vanguard, iShares, SPDR
Market makers
0.0%(-0.2% YoY)
0 filers
Citadel, Susquehanna
Insiders
—
Form 4 — latest per insider
ActiveRetail fundsPassiveMarket makersRetail direct
Top holders
| Fund | $ value | Cost basis | Δ QoQ | Δ YoY | α life | Fund AUM |
|---|---|---|---|---|---|---|
| Solas Capital Management, LLC | $6.0M | $1.40 | +$6.0M | +$6.0M | -1.8% | $174M |
| Alyeska Investment Group, L.P. | $3.5M | $1.40 | +$3.5M | +$3.5M | -0.5% | $35.33B |
| VANGUARD CAPITAL MANAGEMENT LLCPassive | $2.9M | $1.40 | +$2.9M | +$2.9M | — | $4.04T |
| 683 Capital Management, LLC | $1.5M | $1.40 | +$1.5M | +$1.5M | -2.2% | $1.02B |
| Centric Wealth Management | $1.1M | $1.79 | +$294K | +$1.0M | -1.5% | $500M |
| Cable Car Capital, LP | $908K | $1.40 | +$908K | +$908K | -23.4% | $238M |
| Bleichroeder LP | $700K | $1.40 | +$700K | +$700K | -2.8% | $579M |
| GEODE CAPITAL MANAGEMENT, LLCPassive | $505K | $2.29 | +$89K | +$205K | +2.3% | $1.61T |
| VANGUARD FIDUCIARY TRUST COPassive | $279K | $1.40 | +$279K | +$279K | — | $395.83B |
| STATE STREET CORPPassive | $195K | $1.70 | +$89K | +$120K | -0.2% | $2.89T |
| BlackRock, Inc.Passive | $179K | $2.36 | +$29K | +$61K | -0.2% | $5.69T |
| CORSAIR CAPITAL MANAGEMENT, L.P. | $140K | $1.40 | +$140K | +$140K | +0.6% | $673M |
| NORTHERN TRUST CORPPassive | $74K | $1.78 | +$19K | +$19K | -0.2% | $755.34B |
| UBS Group AG | $73K | $1.85 | +$70K | +$72K | -0.3% | $562.11B |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $50K | $1.87 | +$0 | +$0 | -2.3% | $4.93B |
| Creative Planning | $40K | $1.53 | −$0 | +$40K | -0.7% | $144.46B |
| RITHOLTZ WEALTH MANAGEMENT | $32K | $1.53 | +$0 | +$32K | +0.2% | $5.76B |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $28K | $1.40 | +$28K | +$28K | +0.1% | $19.92B |
| Centerpoint Advisory Group | $22K | $1.80 | +$0 | +$22K | -0.2% | $133M |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $20K | $1.25 | +$0 | +$0 | -0.0% | $45.12B |
Cost basis is a volume-weighted estimate from accumulation periods within our 13F history; holders who built their position before our window started will show a stale basis. % above the cost basis is the unrealized gain at the current price.
Trading behavior
Smart-money alpha (lifetime, %/qtr)BEARISH
Holders
-2.87%
avg per quarter
Holders (ex-self)
-2.87%
excl. this stock
Buyers (this Q)
-3.03%
18 buyers · $0.02B in
Sellers (this Q)
-0.55%
2 sellers · $0.00B out
alpha coverage: 83% of $ has a lifetime-alpha record
Holder behavior on this stocksource: stock
On big dips (−10%+)
-4.3%
how holders react when this stock falls
On quiet Qs
-7.0%
−10% to +10% baseline
On rallies (+10%+)
+0.6%
how they react when this stock rises
Holders' portfolio flow this Q
-2.1%
outflows — trims may be forced
Sellers' portfolio flow this Q
+9.2%
Sellers grew AUM elsewhere — opinionated cut of this stock.
▸ Compare to holder-profile behavior (across all their stocks)
Holder dip (any stock)
+2.9%
Holder mid (any stock)
-4.0%
Holder rally (any stock)
-14.0%
Biggest decreases this quarter
New buyers this quarter
Solas Capital Management, LLC+$0.01Bα-1.8Alyeska Investment Group, L.P.+$0.00Bα-0.5VANGUARD CAPITAL MANAGEMENT LLC+$0.00B683 Capital Management, LLC+$0.00Bα-2.2Cable Car Capital, LP+$0.00Bα-23.4Bleichroeder LP+$0.00Bα-2.8VANGUARD FIDUCIARY TRUST CO+$0.00BCORSAIR CAPITAL MANAGEMENT, L.P.+$0.00Bα+0.6O'SHAUGHNESSY ASSET MANAGEMENT, LLC+$0.00Bα+0.1Vanguard Global Advisers, LLC+$0.00B
Top-5 holders · 81.8%
Solas Capital Management, LLC--
Alyeska Investment Group, L.P.--
VANGUARD CAPITAL MANAGEMENT LLC--
683 Capital Management, LLC--
Centric Wealth Management--
Top Holders Over Time
5-year share-count history (top 10 holders by peak, incl. exited) + price
hover the chart for per-quarter detailprice (right axis)
Solas Capital Management, LLC4.3MAlyeska Investment Group, L.P.2.5MHalter Ferguson Financial Inc.—683 Capital Management, LLC1.1MCentric Wealth Management797KCable Car Capital, LP649KLynwood Capital Management Inc.—Bleichroeder LP500KMARSHALL WACE, LLP—BRIDGEWAY CAPITAL MANAGEMENT, LLC36K
Corporate
Insider Trading (last 12mo)
Open-market only (Form 4 P-Purchase + S-Sale). Excludes grants, option exercises, tax withholding, gifts.
Officers & directors
Buys ($, 12mo)
$735K
12 txns · 4 insiders · 566,485 sh
Sells ($, 12mo)
$0
0 txns · 0 insiders · 0 sh
Major holders (≥10% beneficial owners)
Buys ($, 12mo)
$158K
5 txns · 1 insider · 144,300 sh
Sells ($, 12mo)
$0
0 txns · 0 insiders · 0 sh
Recent transactions
| Date | Side | Insider | Title | Shares | Price | Dollars | Owned $ |
|---|---|---|---|---|---|---|---|
| 2025-12-22 | BUY | CHAOUKI STEVEN M | director | 81,698 | $1.29 | $106K | $196K |
| 2025-12-22 | BUY | Smith Stan | director | 114,378 | $1.29 | $148K | $1.84M |
| 2025-12-22 | BUY | Louie Ngar Yee | director | 163,398 | $1.29 | $211K | $1.61M |
| 2025-12-05 | BUY | Smith Stan | director | 13,740 | $1.20 | $16K | $5K |
| 2025-11-28 | BUY | Luput Cristian | director | 18,145 | $1.11 | $20K | $488K |
| 2025-11-28 | BUY | Vitoc Vlad | director, 10 percent owner, officer: Chief Executive Officer | 100,000 | $1.14 | $114K | $1.03M |
| 2025-11-26 | BUY | Smith Stan | director | 15,000 | $1.04 | $16K | $1.42M |
| 2025-11-26 | BUY | Vitoc Vlad | director, 10 percent owner, officer: Chief Executive Officer | 22,000 | $1.05 | $23K | $893K |
| 2025-11-26 | BUY | Luput Cristian | director | 20,000 | $1.08 | $22K | $453K |
| 2025-11-25 | BUY | Luput Cristian | director | 10,000 | $0.98 | $10K | $391K |
| 2025-11-25 | BUY | Smith Stan | director | 15,000 | $0.98 | $15K | $1.32M |
| 2025-11-25 | BUY | Vitoc Vlad | director, 10 percent owner, officer: Chief Executive Officer | 10,500 | $0.97 | $10K | $803K |
| 2025-11-24 | BUY | Smith Stan | director | 10,000 | $0.99 | $10K | $1.32M |
| 2025-11-24 | BUY | Vitoc Vlad | director, 10 percent owner, officer: Chief Executive Officer | 10,000 | $0.99 | $10K | $812K |
| 2025-11-21 | BUY | Vitoc Vlad | director, 10 percent owner, officer: Chief Executive Officer | 1,800 | $0.92 | $2K | $746K |
| 2025-10-01 | BUY | Smith Stan | director | 38,460 | $1.44 | $55K | $1.90M |
| 2025-06-03 | BUY | Smith Stan | director | 66,666 | $1.60 | $107K | $2.09M |
Order Flow (FINRA, ~3w lag)
51.3%retail+0.8pp
10.1%dark-1.7pp
week of 2026-04-13
Off-exchange volume from FINRA. Retail = non-ATS (wholesaler PFOF + broker internalization). Dark = ATS (dark-pool crossing networks, institutional). Lit-exchange = remainder.
Filing Risk Analysis
Filing Risk Scores
MAIA Biotechnology: A Dilution Machine Pivoting to Crypto Speculation While Facing Imminent Insolvency
Overall Risk
9/10
Fraud
4/10
Dilution
10/10
Insolvency
10/10
Earnings Overstated
2/10
Hidden Liabilities
6/10
Legal
3/10
Audit Warnings
9/10
Hidden Upside
3/10
Contextually Acceptable
3/10